¼¼°èÀÇ ÃµÀå°üÀý °íÁ¤¼ú ½ÃÀå
Sacroiliac Joint Fusion
»óǰÄÚµå : 1777531
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 374 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÃµÀå°üÀý °íÁ¤¼ú ½ÃÀåÀº 2030³â±îÁö 25¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 8¾ï 3,830¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â õÀå°üÀý °íÁ¤¼ú ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 20.4%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 25¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÅðÇ༺ õÀå°üÀý¿°Àº CAGR 22.3%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 17¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. õ°ñ ÆÄ±« ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR16.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 2¾ï 2,840¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR26.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÃµÀå°üÀý °íÁ¤¼ú ½ÃÀåÀº 2024³â¿¡ 2¾ï 2,840¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â°£ CAGR 26.9%·Î 2030³â±îÁö 5¾ï 8,940¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, °¢°¢ ºÐ¼® ±â°£ Áß¿¡ 15.0%¿Í 18.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 16.3%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ÃµÀå°üÀý °íÁ¤¼ú ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

õÀå°üÀý °íÁ¤¼úÀÌ Á¤Çü¿Ü°ú Ä¡·á¿¡¼­ ÁÖ¸ñ¹Þ´Â ÀÌÀ¯´Â?

õÀå°üÀý(SI) ±â´É Àå¾Ö´Â ¿äÅëÀÇ ½É°¢ÇÑ ¿øÀÎÀ¸·Î Àü ¼¼°è ¼ö¹é¸¸ ¸íÀÇ »ç¶÷µéÀÌ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. SI °üÀý °ü·Ã ÅëÁõ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ õÀå°üÀý °íÁ¤¼úÀº ¹°¸®Ä¡·á, ÅëÁõ °ü¸®, ÁÖ»ç µî º¸Á¸Àû ¿ä¹ý¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â ȯÀÚ¸¦ À§ÇÑ Ä¡·á¹ýÀ¸·Î ³Î¸® äÅõǰí ÀÖ½À´Ï´Ù. ÀÌ ¼ö¼úÀº ÀÓÇöõÆ®³ª »À À̽ÄÀ» ÀÌ¿ëÇÏ¿© SI °üÀýÀ» ¾ÈÁ¤È­½Ã۰í ÅëÁõÀ» °¨¼Ò½ÃŰ¸ç ¿îµ¿¼ºÀ» °³¼±ÇÏ´Â ¼ö¼úÀÔ´Ï´Ù. ÅðÇ༺ °üÀý ÁúȯÀÇ À¯º´·ü Áõ°¡, ¿Ü»ó °ü·Ã ¼Õ»ó, ºñ¸¸ ¹× Àå½Ã°£ ¾É¾ÆÀÖ´Â °Í°ú °°Àº »ýȰ½À°ü ¿äÀÎÀÌ SI °üÀý °íÁ¤¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÃÖ¼Òħ½À ¼ö¼ú ±â¼úÀÇ ¹ßÀüÀ¸·Î ¼ö¼úÀÇ ¾ÈÀü¼º, ȸº¹½Ã°£ ´ÜÃà, ȯÀÚ ¿¹ÈÄ °³¼±ÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿Í ÀÇ·áºñ ÁöÃâ Áõ°¡·Î ÀÎÇØ õÀå°üÀý °íÁ¤¼ú ½ÃÀåÀº °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

¾î¶² ±â¼ú Çõ½ÅÀÌ ÃµÀå°üÀý °íÁ¤¼úÀ» º¯È­½Ã۰í Àִ°¡?

ÀÇ·á±â¼úÀÇ ¹ßÀüÀ¸·Î SI °üÀý °íÁ¤¼úÀÇ Á¤È®¼º°ú À¯È¿¼ºÀÌ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ÃÖ¼Òħ½À¼ö¼ú(MIS) ±â¼úÀÇ ¹ß´Þ·Î ¼ö¼ú½Ã°£, ¼ö¼ú ÈÄ ÅëÁõ, ȸº¹±â°£ÀÌ ´ÜÃàµÇ¾ú½À´Ï´Ù. ¿µ»óÀ¯µµ ³×ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ°ú ·Îº¿ º¸Á¶ ¼ö¼úÀº ¼ö¼úÀÇ Á¤È®µµ¸¦ ³ôÀ̰í ÇÕº´Áõ À§ÇèÀ» °¨¼Ò½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƼŸ´½À̳ª 3D ÇÁ¸°ÆÃµÈ ´Ù°ø¼º Àç·á·Î ¸¸µç »ýüÀûÇÕ¼º ÀÓÇöõÆ®´Â »ÀÀÇ ¼ºÀå°ú ¾ÈÁ¤¼ºÀ» ÃËÁøÇÏ¿© À¯ÇÕ ¼ö¼úÀÇ ¼º°ø·üÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. °ñÀÌ½Ä ´ëü¹°À̳ª ¼ºÀåÀÎÀÚ µî »ý¹°ÇÐÀû Á¦Á¦ÀÇ »ç¿ëµµ À¯ÇÕÀÇ ¼º°ú¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ¸·Î ÀÎÇØ õÀå°üÀý °íÁ¤¼úÀº ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ¿¡°Ô ´õ¿í ¸Å·ÂÀûÀÎ ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù.

SI °üÀý °íÁ¤¼ú ¼ö¿ä¸¦ ÁÖµµÇϴ ȯÀÚ ±×·ì°ú ÇコÄÉ¾î ºÐ¾ß´Â?

õÀå°üÀý °íÁ¤¼úÀÇ ÁÖ¿ä ȯÀÚ±º¿¡´Â ¸¸¼º ¿äÅë, °üÀý¿°, ¿Ü»ó °ü·Ã, ÀӽŠÈÄ °ñ¹Ý ºÒ¾ÈÁ¤¼º µîÀ¸·Î °íÅë¹Þ´Â »ç¶÷µéÀÌ ÀÖ½À´Ï´Ù. ÅðÇ༺ °üÀý Áúȯ¿¡ °É¸®±â ½¬¿î ³ëÀΠȯÀÚµéÀº ½ÃÀåÀÇ »ó´ç ºÎºÐÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ºÆ÷Ã÷ ¼±¼ö³ª À°Ã¼ÀûÀ¸·Î Èûµç Á÷¾÷¿¡ Á¾»çÇÏ´Â »ç¶÷µéÀº SI °üÀý ±â´É Àå¾ÖÀÇ À§ÇèÀÌ ³ô¾Æ ¼ö¼úÀû °³ÀÔ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º´¿ø ¹× ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ºÐ¾ß¿¡¼­´Â ºñ¿ë È¿À²ÀûÀÎ ¿Ü·¡ ¼ö¼úÀÇ ¼±Åðú °³¼±µÈ »óȯ Á¤Ã¥À¸·Î ÀÎÇØ SI °üÀý °íÁ¤¼úÀÇ µµÀÔÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. SI °üÀý °íÁ¤¼úÀ» Ä¡·á¿¡ µµÀÔÇÏ´Â Á¤Çü¿Ü°ú Àü¹®ÀÇ¿Í ÅëÁõ °ü¸® Ŭ¸®´ÐÀÌ ´Ã¾î³²¿¡ µû¶ó ½ÃÀåÀº ´õ¿í È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

õÀå°üÀý °íÁ¤¼ú ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

õÀå°üÀý °íÁ¤¼ú ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº SI °üÀý ±â´É Àå¾Ö¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÃÖ¼Ò Ä§½À ¼ö¼úÀÇ ¹ßÀü, ÅðÇ༺ °üÀý Áúȯ¿¡ Ãë¾àÇÑ °í·ÉÈ­ Àα¸ Áõ°¡ÀÔ´Ï´Ù. ·Îº¿º¸Á¶¼ö¼ú°ú ¿µ»óÀ¯µµ ³×ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀÇ µµÀÔ È®´ë´Â ¼ö¼ú ¼ºÀûÀ» Çâ»ó½ÃÄÑ ½ÃÀå µµÀÔÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÅëÁõ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡Çϸ鼭 ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾É¾Æ¼­ »ýȰÇÏ´Â »ýȰ½À°ü°ú ºñ¸¸ Áõ°¡·Î ÀÎÇØ ¿äÅëÀÇ ¹ß»ý·üÀÌ ³ô¾ÆÁ® ¼ö¼úÀû ÇØ°áÃ¥À» ã´Â ȯÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¬±¸¸¦ ÅëÇØ Ä¡·á¹ýÀÌ Áö¼ÓÀûÀ¸·Î °³¼±µÇ°í ÀÖ¾î õÀå°üÀý °íÁ¤¼ú ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

ÀûÀÀÁõ(º¯¼ºÃµÀå°üÀý¿°, ¼±°ñÆÄ±«, ¿Ü»ó);Ä¡·á À¯Çü(¼ö¼ú, ÁÖ»ç, RF ÀýÁ¦);ÃÖÁ¾»ç¿ëÀÚ(º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Sacroiliac Joint Fusion Market to Reach US$2.5 Billion by 2030

The global market for Sacroiliac Joint Fusion estimated at US$838.3 Million in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 20.4% over the analysis period 2024-2030. Degenerative Sacroiliitis, one of the segments analyzed in the report, is expected to record a 22.3% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Sacral Disruption segment is estimated at 16.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$228.4 Million While China is Forecast to Grow at 26.9% CAGR

The Sacroiliac Joint Fusion market in the U.S. is estimated at US$228.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$589.4 Million by the year 2030 trailing a CAGR of 26.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.0% and 18.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.3% CAGR.

Global Sacroiliac Joint Fusion Market - Key Trends & Drivers Summarized

Why Is Sacroiliac Joint Fusion Gaining Prominence In Orthopedic Treatments?

Sacroiliac (SI) joint dysfunction is a significant cause of lower back pain, affecting millions of people worldwide. As awareness of SI joint-related pain grows, sacroiliac joint fusion is becoming a widely adopted treatment option for patients who do not respond to conservative therapies such as physical therapy, pain management, and injections. The procedure involves stabilizing the SI joint using implants or bone grafts to reduce pain and improve mobility. The increasing prevalence of degenerative joint diseases, trauma-related injuries, and lifestyle factors such as obesity and prolonged sitting are fueling demand for SI joint fusion surgeries. Additionally, advancements in minimally invasive surgical techniques are making the procedure safer, reducing recovery times, and improving patient outcomes. With an aging global population and rising healthcare expenditure, the sacroiliac joint fusion market is experiencing strong growth.

What Technological Innovations Are Transforming Sacroiliac Joint Fusion Procedures?

Advancements in medical technology are significantly enhancing the precision and effectiveness of SI joint fusion procedures. The development of minimally invasive surgical (MIS) techniques has reduced operative times, post-surgical pain, and recovery periods. Image-guided navigation systems and robotic-assisted surgery are improving surgical accuracy, reducing the risk of complications. Additionally, biocompatible implants made from titanium and 3D-printed porous materials are increasing the success rates of fusion procedures by promoting bone growth and stability. The use of biologics, such as bone graft substitutes and growth factors, is also enhancing fusion outcomes. These innovations are making sacroiliac joint fusion a more attractive option for both patients and healthcare providers.

Which Patient Groups And Healthcare Sectors Are Driving The Demand For SI Joint Fusion?

The primary patient groups benefiting from sacroiliac joint fusion include individuals suffering from chronic lower back pain, arthritis, trauma-related injuries, and post-pregnancy pelvic instability. Geriatric patients, who are more prone to degenerative joint conditions, represent a significant portion of the market. Additionally, athletes and individuals engaged in physically demanding jobs are at higher risk of SI joint dysfunction, increasing demand for surgical interventions. The hospital and ambulatory surgery center (ASC) sectors are experiencing heightened adoption of SI joint fusion procedures due to improved reimbursement policies and cost-effective outpatient surgical options. As more orthopedic specialists and pain management clinics incorporate SI joint fusion into their treatment offerings, the market is expected to expand further.

What Factors Are Fueling The Growth Of The Sacroiliac Joint Fusion Market?

The growth in the sacroiliac joint fusion market is driven by increasing awareness of SI joint dysfunction, advancements in minimally invasive surgery, and a rising aging population prone to degenerative joint diseases. The growing adoption of robotic-assisted procedures and image-guided navigation systems is improving surgical outcomes, further driving market adoption. Favorable reimbursement policies and increased healthcare expenditure on pain management solutions are also contributing to market growth. Additionally, the rising prevalence of sedentary lifestyles and obesity is increasing the incidence of lower back pain, prompting more patients to seek surgical solutions. As research continues to refine treatment approaches, the sacroiliac joint fusion market is poised for sustained expansion.

SCOPE OF STUDY:

The report analyzes the Sacroiliac Joint Fusion market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Degenerative Sacroiliitis, Sacral Disruption, Trauma); Treatment Type (Surgery, Injections, RF Ablation); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â